Actoverco’s Active participation in the 21st International Congress on Cardiovascular Updates in Milad Tower International Conference Hall

Author:
Actoverco
Date:
12 August 2019
34

This congress started on August 20 and will continue until tomorrow, August 23.

This congress started on August 20 and will continue until tomorrow, August 23.

Actoverco currently has 10 active drugs on the market in three lines related to the field of cardiovascular disease, and plans to launch at least two other new drugs in this field by the end of this year.

Related Posts

M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

29 December 2024
M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

11 December 2024
4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

8 December 2024
4R4A0991

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

16 October 2024
WhatsApp Image 2024-09-23 at 10.46.39 AM

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

30 September 2024